HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Osteochondroma

Osteochondroma

Osteochondroma, a benign bone tumor, has garnered recent attention in cancer research due to its potential for malignant transformation. While typically non-cancerous, osteochondromas possess a small risk of evolving into chondrosarcomas, a type of bone cancer. Researchers are delving into the genetic and molecular mechanisms underlying this transformation, aiming to identify predictive markers and therapeutic targets. Advanced imaging techniques and molecular profiling enable early detection of malignant progression, facilitating timely intervention. Moreover, studies explore the tumor microenvironment and its role in fostering malignant transformation, offering insights into novel treatment strategies. By elucidating the complexities of osteochondroma progression, ongoing research endeavors strive to improve diagnostic accuracy, refine risk stratification, and ultimately enhance patient outcomes in the realm of bone cancer.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp